Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $2.26 Million - $2.62 Million
-20,300 Reduced 7.93%
235,700 $26.8 Million
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $16 Million - $17.2 Million
-129,200 Reduced 33.54%
256,000 $31.7 Million
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $16.2 Million - $18.9 Million
142,900 Added 58.98%
385,200 $50.8 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $1.57 Million - $1.71 Million
15,700 Added 6.93%
242,300 $26.4 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $8.14 Million - $9.04 Million
-79,100 Reduced 25.88%
226,600 $23.3 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $18.1 Million - $19.7 Million
166,500 Added 119.61%
305,700 $35.3 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $4.68 Million - $5.23 Million
45,500 Added 48.56%
139,200 $14.8 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $113,672 - $145,743
-1,300 Reduced 1.37%
93,700 $10.4 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $329,667 - $370,344
3,900 Added 4.28%
95,000 $8.18 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $14.6 Million - $16.6 Million
-175,100 Reduced 65.78%
91,100 $8.31 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $25.2 Million - $28.2 Million
-342,400 Reduced 56.26%
266,200 $21.8 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $26.8 Million - $33.6 Million
370,800 Added 155.93%
608,600 $46.6 Million
Q3 2021

Nov 10, 2021

BUY
$71.68 - $78.83 $17 Million - $18.7 Million
237,800 New
237,800 $17.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.